Joseph S Murray

Title: Innovations of Joseph S. Murray

Introduction

Joseph S. Murray is a notable inventor based in Topeka, Kansas. He has made significant contributions to the field of biochemistry, particularly in the development of peptide inhibitors. His work focuses on advancing our understanding of immune responses through innovative peptide sequences.

Latest Patents

Joseph S. Murray holds a patent for the "Signal-1/signal-2 bifunctional peptide inhibitors." This novel peptide sequence has the general formula AB, where A and B represent chains of amino acid residues. The A chain is designed to bind with a major histocompatibility complex on an antigen-presenting cell, while the B chain binds with a Signal-2 receptor on the same cell. The patent also describes preferred forms of the peptide sequence that include an X chain positioned between the A and B chains. This innovative peptide sequence is capable of shifting immune responses, which has potential implications for therapeutic applications.

Career Highlights

Joseph S. Murray is affiliated with the University of Kansas Medical Center Research Institute. His work at this institution has allowed him to explore the complexities of immune modulation through peptide technology. His research has contributed to the understanding of how immune responses can be manipulated for better health outcomes.

Collaborations

Joseph has collaborated with notable colleagues such as Teruna J. Siahaan and Yongbo Hu. These collaborations have enriched his research and expanded the impact of his innovations in the field.

Conclusion

Joseph S. Murray's contributions to peptide inhibitors represent a significant advancement in immunology. His innovative work continues to pave the way for future research and potential therapeutic applications.